Home >> Marketplace Directory >> Women’s health care lab, 9/14

Women’s health care lab, 9/14

image_pdfCreate PDF

At the AACC Show 2014

September 2014—Medical experts representing Vermillion, a multivariate diagnostics company focused on gynecologic cancers and women’s health, presented on Aspira Labs, its new CLIA-certified reference laboratory. Aspira Labs provides expert diagnostic services, including OVA1 and Longitudinal CA 125 testing, which support clinical decision-making and personalized treatment plans. Aspira Labs was established for the purpose of delivering clear, intuitive, and timely results with a focus on providing physicians and laboratories with a personalized reference laboratory experience, including readily accessible expert consultations.

In addition to OVA1, the lab offers physicians Longitudinal CA 125 testing. The CA 125 baseline level is obtained from OVA1 prior to initial surgery and diagnosis of ovarian cancer. When ordered by the gynecologic oncologist as part of postsurgical monitoring, the lab provides a multipoint CA 125 graph comparing the baseline to a newly measured CA 125 result. This test report, in accordance with FDA-cleared use of CA 125, may help health care professionals detect residual disease or ovarian cancer recurrence.

The lab is located near Austin, Tex., and is now operational.

Vermillion, 512-519-0400

CAP TODAY
X